Organisation: Rezular

A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC

AGI sells for less than €7m five years after being valued at €85m

IRISH pharmaceutical company AGI Therapeutics has been sold for less than €7 million, less than five years after being valued at €85m.

Tue, 10 Jan, 2012

AGI Therapeutics to diversify after disappointing drug test

AGI Therapeutics will widen its focus beyond gastro-intestinal disorders and develop alternative uses for its flagship Rezular product after disappointing clinical trials earlier this year.

Wed, 23 Sep, 2009

AGI hits losses of $1.5m, but says trials are on track

IRISH pharmaceutical company AGI Therapeutics has seen its first half losses widen by about $1.5 million (€1.05m).

Wed, 10 Sep, 2008